|
The
Diabetes Dilemma: Combating An American Health Crisis
Release
Date: April 12, 2007
Expiration Date: July 11, 2009
Target
Audience
This activity is designed for a wide range of practitioners particularly
managed health care professionals seeking contemporary information and
innovative strategies for appropriate diabetes management.
Activity Overview
Although the incidence of diabetes is intensifying, recent developments
have sparked new optimism for treating diabetes patients. Therapeutic
and delivery advances easing concerns about initiating insulin therapy
and allowing effective glycemic control have given both scientists and
health care practitioners new ways at looking at this disease. With the
emergence of innovative therapies, the managed care industry must adapt
by not only finding cost-effective means for delivering the pharmaceuticals
but by also addressing care management, drug utilization review, and patient
education.
How can we
educate health care providers on the fifth leading cause of death and
equip them with tools and information to improve the health of millions?
This activity will give you information about emerging therapies and treatment
protocols, strategies to encourage therapeutic adherence and improve decision-making
through pharmacoeconomic evaluation, and describe best practice models
that showcase improved patient outcomes and quality-of-life while reducing
overall health care expenditures.
Educational
Objectives
Upon completion of this activity, participants should be able to:
- Evaluate
the benefits and risks of current therapies and treatment protocols
for the treatment of patients with type 1 and type 2 diabetes in order
to develop a roadmap to appropriate care.
- Analyze
the epidemic complexity of diabetes and evaluate the advantages of adequately
treating individuals with insulin in order to reach goal and ultimately
improve patient outcomes.
- Return
to practice with an innovative approach to treat patients with diabetes
through the use of new therapeutic options and delivery devices to encourage
adherence.
- Apply
evidence-based best practice strategies and consider pharmacoeconomic
data when determining the most effective treatment regimen.
- Analyze
the complexity of co-morbid conditions associated with diabetes and
evaluate the importance of adequately diagnosing and treating co-morbidities
to improve outcomes and manage costs.
- Propose
contemporary approaches by employers to manage cost, determine value,
and encourage healthy, productive employees.
Accreditation
Statements
Physician
 |
This
activity has been planned and implemented in accordance with the Essential
Areas and Policies of the Accreditation Council for Continuing Medical
Education through the joint sponsorship of Creative Educational Concepts,
Inc. and AMCP Horizons. Creative Educational Concepts, Inc. is accredited
by the ACCME to provide continuing medical education for physicians. |
CEC designates
this educational activity for a maximum of 2.0
AMA PRA Category 1 Credits™. Physicians should only claim credit
commensurate with the extent of their participation in the activity.
AAFP Credit
This activity has been reviewed and is acceptable for up to 2.0 Prescribed credit(s) by the American Academy of Family Physicians. AAFP accreditation begins 07/01/07. Term of approval is for one-year(s) from this date, with option for yearly renewal.
Pharmacy
 |
Creative
Educational Concepts, Inc. (CEC) is accredited by the Accreditation
Council for Pharmacy Education as a provider of continuing pharmacy
education. This program has been assigned ACPE 245-999-07-002-H04 and will award 2.0 contact
hours (.20 CEUs) of continuing
pharmacy education credit. CEC complies with the Criteria for Quality
for continuing education programming. Statements of credit will be
issued automatically on line. |
Nurses
Eastern
Kentucky University, the Division of Continuing Education and Development,
is accredited as a provider of continuing nursing education by the American
Nurses Credentialing Center's Commission on Accreditation.
 |
Eastern
Kentucky University, the Division of Continuing Education and Development,
designates this educational activity for 2.0 contact
hours. This activity will provide 2.0 contact
hours of nursing credit. Licensees are required to retain certificates
of completion for a period of five (5) years following the end of
their licensure period and submit certificate to the Board of Nursing
only upon request. |
Case Managers
This activity has been approved by the Commission for Case Manager
Certification through 12/31/08 for up to 2.0 clock hours of continuing
education credit.
Faculty Information and Disclosures
Lawrence Blonde, MD, FACP, FACE
Director, Ochsner Diabetes Clinical Research Unit
Endocrinology, Diabetes and Metabolism
Associate Internal Medicine Residency Program Director
Department of Internal Medicine
Ochsner Clinic Foundation
New Orleans, Louisiana
Dr. Blonde has indicated he receives grant/research support and is a clinical investigator and/or consultant for Amylin Pharmaceuticals, Inc., AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, MannKind Corporation, Novo Nordisk A/S, Novartis AG, Pfizer, Inc., and Sanofi Aventis. He also serves on the speakers' bureau for Abbott Laboratories, Amylin Pharmaceuticals, Inc., Eli Lilly and Company, GlaxoSmithKline PLC, Merck & Co., Inc., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., and Sanofi Aventis. He is a consultant for Abbot Laboratories, Amylin Pharmaceuticals, Lifescan, Inc., Merck & Co., Novartis AG, Pfizer, Inc., and Sanofi Aventis. He is a stock holder for Amylin Pharmaceuticals, Inc. and Pfizer, Inc.
H. Eric Cannon, PharmD
Director of Pharmacy Services
Director of Health and Wellness
SelectHealth, an Intermountain Healthcare Company
Salt Lake City, Utah
Dr. Cannon has indicated he receives grant/research support from Eli Lilly and Novo Nordisk. He also serves as a consultant to Amylin, Merck, and Novartis.
Christopher V. Goff, JD, MA
President & CEO
Employers Health Purchasing Corporation of Ohio
Canton, Ohio
Mr. Goff has indicated he receives grant/research support from Novo Nordisk.
Instructions
To receive a statement of credit, you must:
- Review
the full content of the activity.
- Successfully
complete the post-test with a minimum grade of 70% or higher.
- You will
have two (2) opportunities to successfully complete the activity.
Your statement
of credit will be issued immediately upon successful completion of the
test and submission of the evaluation form.
Fee
There is no fee to participate.
Disclosure
Declaration
It is the policy of Creative Educational Concepts, Inc. and AMCP Horizons,
LLC to ensure independence, balance, objectivity, scientific rigor, and
integrity in their continuing education activities.
Those involved
in the development of this continuing education activity have made all
reasonable efforts to ensure that information contained herein is accurate
in accordance with the latest available scientific knowledge at the time
of accreditation of this continuing education activity. Information regarding
drugs (e.g., their administration, dosages, contraindications, adverse
reactions, interactions, special warnings, and precautions) and drug delivery
systems is subject to change, however, and the reader is advised to check
the manufacturer's package insert for information concerning recommended
dosage and potential problems or cautions prior to dispensing or administering
the drug or using the drug delivery systems.
Any medications
or treatment methods suggested in this CE activity should not be used
by the practitioner without evaluation of their patient's condition(s)
and possible contraindication(s) or danger(s) of use of any specific medication.
Unlabeled
Use Disclosure
This activity will not include discussions of products or devices that
are not currently approved for use by the Food and Drug Administration
(FDA), or are currently investigational.
Supporting
Organization
|
|
This
activity is supported through an educational grant from Novo Nordisk,
Inc. |
Viewing
Requirements
|
